ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy Claims in Advertisement

2 days ago 3

Noor Ul Ain Rehman

Tue, March 31, 2026 astatine 10:06 AM CDT 2 min read

ImmunityBio Inc. (NASDAQ:IBRX) is 1 of the champion precocious maturation healthcare stocks to bargain now. On March 24, the FDA posted a informing missive to its site, stating that its Office of Prescription Drug Promotion “reviewed the promotional communications, a direct-to-consumer broadcast advertisement submitted by ImmunityBio Inc. (NASDAQ:IBRX), nether screen of Form FDA 2253 and a DTC podcast titled, ‘Is the FDA BLOCKING Life Saving Cancer Treatments?’ regarding Anktiva…”. It added that complaints were received by the FDA Bad Ad Program regarding promotional communications for Anktiva, and the FDA determined that “the TV advertisement and podcast are mendacious oregon misleading.

ImmunityBio (IBRX) Jumps 18% connected  Anktiva Access Expansion

ImmunityBio (IBRX) Jumps 18% connected Anktiva Access Expansion

Reuters reported the aforesaid time that ImmunityBio Inc. (NASDAQ:IBRX) has been directed by the FDA to cease the TV advertisement and podcast oregon instrumentality it down, and besides taxable a written effect wrong 15 moving days ​addressing the concerns described successful the letter. The institution told Reuters successful an email that the process of reviewing the agency’s missive has begun, and it aims to respond wrong the requested timeframe ‌to ⁠address the matter.

ImmunityBio, Inc. (NASDAQ:IBRX) is simply a clinical-stage immunotherapy institution that develops next-generation therapies to dainty crab and infectious diseases. Its immunotherapy level activates the adaptive and innate immune systems to make semipermanent immunological memory.

While we admit the imaginable of IBRX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article